Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation.
- Former FDA commissioner Andrew von Eschenbach elected to Viamet board
Viamet Pharmaceuticals Inc., which discovers and develops inhibitors of key metalloenzymes, announced that Andrew von Eschenbach, M.D., former Food & Drug Administration commissioner and former director of the U.S. National Cancer Institute (NCI), has joined the company’s board. Dr. von Eschenbach is a recognized leader in urology, prostate cancer research, patient healthcare policy and pharmaceutical regulation.
Read more - NIMHD names first African-American scientific director at NIH
The National Institute on Minority Health and Health Disparities announced the appointment of William G. Coleman, Jr., Ph.D., as the NIMHD’s first permanent scientific director and the first African-American scientific director in the history of the NIH Intramural Research Program. The appointment follows an extensive national search. Dr. Coleman is one of 23 scientific directors at the NIH.
Read more - Lantheus promotes Robert Gaffey to CFO
Lantheus Medical Imaging Inc., a worldwide company in diagnostic imaging, announced the promotion of Robert Gaffey to CFO. He was most recently vice president, Finance and IT. In this expanded role, Mr. Gaffey will add the leadership for investor relations and strategic corporate communications to his current responsibilities of directing the Company’s global financial strategy. Mr. Gaffey will continue to report to Lantheus President and CEO, Don Kiepert.
Read more - Solta Medical Inc. appoints Thomas Yorkey to VP of R&D
Solta Medical Inc. (NSDQ:SLTM), a global leader in the medical aesthetics market, announced the promotion of Thomas Yorkey, Ph.D., to VP of Research & Development, Dr. Yorkey will lead all global R&D initiatives and will report to Clint Carnell, COO at Solta.
Read more - AxoGen signs Brad Hedger as VP of sales
AxoGen Inc. announced hiring Brad Hedger as VP of Sales. This is a new position within AxoGen signifying the continued, aggressive sales growth of the organization.
Read more - Dr. Peter Pronovost to join the board of Cantel Medical Corp.
Cantel Medical Corp. (NYSE:CMN) announced the election of Peter J. Pronovost, M.D., Ph.D. to serve as an independent member of Cantel’s board.
Read more - ICTS Patient Recruitment announces board changes
ICTS, the patient recruitment and clinical trial marketing services company, announced that Sheila H. Ogle, CEO of ICTS, has resigned from the company after 8 years of service. Ogle made the announcement at the ICTS board meeting in December.
Read more - New CEO appointed to MedTech Holdings
MedTech Holdings Inc. a components and contract medical device manufacturer, announced that its board has named Dan Croteau, 45, to serve as the company’s CEO. Croteau succeeds George W. Blank, MedTech’s founding CEO. Blank will assume the role of Chairman of the board of MedTech Holdings.
Read more - DJO Inc. announces planned transition of president and CEO Les Cross
DJO Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, announced the planned retirement of Leslie H. Cross, President and CEO.
Read more - Accuray hires chief marketing officer
Accuray Incorporated (NSDQ:ARAY), a global leader in the field of radiosurgery, announced that Eric Pauwels has joined Accuray as Senior VP and Chief Marketing Officer, effective January 17, 2011.
Read more - Pescatello elected to head New England Biotech Association in 2011-12
Paul Pescatello has been re-elected as Chairman of the New England Biotech Association (NEBA) at the organization’s annual meeting.
Read more - PrognosDx announces appointments of Dr. Garry Nolan to board and Dr. Joseph Presti to scientific advisory board
PrognosDx Health Inc., an epigenetics pioneer harnessing the predictive power of global patterns of histone modifications, announced the appointment of Garry P. Nolan, Ph.D. as Vice Chairman.
Read more - Cenduit sales executive appointed to expand business development
Cenduit, a provider of Interactive Response Technology solutions (IVRS/IWRS) to support multi-continent clinical programs, announced the appointment of Anthony Frankland as the Global Head of Sales and Marketing. Cenduit, a joint venture between Thermo Fisher Scientific and Quintiles, opens the door to a new level of clinical trial support by acting as the central conduit of data between clinical supplies and clinical development.
Read more - WaferGen appoints clinical genomics cancer researcher Dr. Arul M. Chinnaiyan to scientific advisory board
WaferGen Biosystems Inc. (OTC:WGBS), a developer of state-of-the-art genomic analysis systems, announced that it has appointed world-renowned clinical genomics cancer researcher Arul M. Chinnaiyan, M.D., Ph.D., to its scientific advisory board.
Read more - Foundation Medicine appoints Gary Palmer VP, medical affairs and commercial development
Diagnostics company Foundation Medicine Inc. named Gary Palmer as senior VP, medical affairs and commercial development. The role is a newly created position in which Palmer will see through the startup’s cancer tests into clinical tests and commercial development, according to Mass High Tech.
Read more - Transenterix lands surgical device executive to serve as CTO
Richard M. Mueller has been named CTO at TransEnterix.
Read more - Human Genome Sciences appoints Greg Norden to board
Human Genome Sciences Inc. (NSDQ:HGSI) announced that Greg Norden, former Senior VP and CFO of Wyeth, has been appointed to the HGS board.
Read more
